{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Apoptosis", "Ruta angustifolia L. Pers", "cell cycle", "chalepin", "nuclear factor kappa-light-chain-enhancer of activated B cells", "signal transducer and activation of transcription 3"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": [], "GeneralNote": [], "PMID": "29142404", "DateRevised": {"Year": "2022", "Month": "04", "Day": "09"}, "Article": {"ArticleDate": [{"Year": "2017", "Month": "10", "Day": "11"}], "Language": ["eng"], "ELocationID": ["10.4103/pm.pm_13_17"], "Journal": {"ISSN": "0973-1296", "JournalIssue": {"Volume": "13", "Issue": "Suppl 3", "PubDate": {"Year": "2017", "Month": "Oct"}}, "Title": "Pharmacognosy magazine", "ISOAbbreviation": "Pharmacogn Mag"}, "ArticleTitle": "Chalepin: A Compound from <i>Ruta angustifolia</i> L. Pers Exhibits Cell Cycle Arrest at S phase, Suppresses Nuclear Factor-Kappa B (NF-\u03baB) Pathway, Signal Transducer and Activation of Transcription 3 (STAT3) Phosphorylation and Extrinsic Apoptotic Pathway in Non-small Cell Lung Cancer Carcinoma (A549).", "Pagination": {"StartPage": "S489", "EndPage": "S498", "MedlinePgn": "S489-S498"}, "Abstract": {"AbstractText": ["Plants have been a major source of inspiration in developing novel drug compounds in the treatment of various diseases that afflict human beings worldwide. <i>Ruta angustifolia</i> L. Pers known locally as Garuda has been conventionally used for various medicinal purposes such as in the treatment of cancer.", "A dihydrofuranocoumarin named chalepin, which was isolated from the chloroform extract of the plant, was tested on its ability to inhibit molecular pathways of human lung carcinoma (A549) cells.", "Cell cycle analysis and caspase 8 activation were conducted using a flow cytometer, and protein expressions in molecular pathways were determined using Western blot technique.", "Cell cycle analysis showed that cell cycle was arrested at the S phase. Further studies using Western blotting technique showed that cell cycle-related proteins such as cyclins, cyclin-dependent kinases (CDKs), and inhibitors of CDKs correspond to a cell cycle arrest at the S phase. Chalepin also showed inhibition in the expression of inhibitors of apoptosis proteins. Nuclear factor-kappa B (NF-\u03baB) pathway, signal transducer and activation of transcription 3 (STAT-3), cyclooxygenase-2, and c-myc were also downregulated upon treatment with chalepin. Chalepin was found to induce extrinsic apoptotic pathway. Death receptors 4 and 5 showed a dramatic upregulation at 24 h. Analysis of activation of caspase 8 with the flow cytometer showed an increase in activity in a dose- and time-dependent manner. Activation of caspase 8 induced cleavage of BH3-interacting domain death agonist, which initiated a mitochondrial-dependent or -independent apoptosis.", "Chalepin causes S phase cell cycle arrest, NF-\u03baB pathway inhibition, and STAT-3 inhibition, induces extrinsic apoptotic pathway, and could be an excellent chemotherapeutic agent.", "This study reports the capacity of an isolated bioactive compound known as chalepin to suppress the nuclear factor kappa-light-chain-enhancer of activated B cells pathway, signal transducer and activation of transcription 3, and extrinsic apoptotic pathway and also its ability to arrest cell cycle in S phase. This compound was from the leaves of <i>Ruta angustifolia</i> L. Pers. It provides new insight on the ability of this plant in suppressing certain cancers, especially the nonsmall cell lung carcinoma according to this study. <b>Abbreviations used:</b> \u00b0C: Degree Celsius, ANOVA: Analysis of variance, ATCC: American Type Culture Collection, BCL-2: B-Cell CLL/Lymphoma 2, Bcl-xL: B-cell lymphoma extra-large, BH3: Bcl-2 homology 3, BID: BH3-interacting domain death agonist, BIR: Baculovirus inhibitor of apoptosis protein repeat, Caspases: Cysteinyl aspartate-specific proteases, CDK: Cyclin-dependent kinase, CO<sub>2</sub>: Carbon dioxide, CST: Cell signaling technologies, DISC: Death-inducing signaling complex, DMSO: Dimethyl sulfoxide, DNA: Deoxyribonucleic acid, DR4: Death receptor 4, DR5: Death receptor 5, E1a: Adenovirus early region 1A, ECL: Enhanced chemiluminescence, EDTA: Ethylenediaminetetraacetic acid, ELISA: Enzyme-linked immunosorbent assay, etc.: Etcetera, FADD: Fas-associated protein with death domain, FBS: Fetal bovine serum, FITC: Fluorescein isothiocyanate, G1: Gap 1, G2: Gap 2, HPLC: High-performance liquid chromatography, HRP: Horseradish peroxidase, IAPs: Inhibitor of apoptosis proteins, IC50: Inhibitory concentration at half maximal inhibitory, IKK-\u03b1: Inhibitor of nuclear factor kappa-B kinase subunit alpha, IKK-\u03b2: Inhibitor of nuclear factor kappa-B kinase subunit beta, IKK-\u03b3: Inhibitor of nuclear factor kappa-B kinase subunit gamma, IKK: I\u03baB kinase, IkB\u03b1: Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha, m: Meter, M: Mitotic, mm: Millimeter, mRNA: Messenger ribonucleic acid, NaCl: Sodium chloride, NaVO4: Sodium orthovanadate, NEMO: NF-Kappa-B essential modulator, NF-\u03baB: Nuclear factor kappa-light chain-enhancer of activated B cells, NSCLC: Nonsmall cell lung carcinoma, PBS: Phosphate buffered saline, PGE2: Prostaglandin E2, PI: Propidium iodide, PMSF: Phenylmethylsulfonyl fluoride, pRB: Phosphorylated retinoblastoma, <i>R. angustifolia</i>: <i>Ruta angustifolia</i> L. Pers, Rb: Retinoblastoma, rpm: Rotation per minute, RPMI: Roswell Park Memorial Institute, S phase: Synthesis phase, SD: Standard deviation, SDS-PAGE: Sodium dodecyl sulfate-polyacrylamide gel electrophoresis, Smac: Second mitochondria-derived activator of caspase, SPSS: Statistical Package for the Social Sciences, STAT3: Signal transducer and activation of transcription 3, tBID: Truncated BID, TNF: Tumor necrosis factor, TRADD: Tumor necrosis factor receptor type-1 associated death domain, TRAIL: TNF-related apoptosis- inducing ligand, USA: United States of America, v/v: Volume over volume."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Biological Sciences, Faculty of Science, University of Malaya, Kuala Lumpur, Malaysia."}], "LastName": "Richardson", "ForeName": "Jaime Stella Moses", "Initials": "JSM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Biological Sciences, Faculty of Science, University of Malaya, Kuala Lumpur, Malaysia."}], "LastName": "Aminudin", "ForeName": "Norhaniza", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Biological Sciences, Faculty of Science, University of Malaya, Kuala Lumpur, Malaysia."}], "LastName": "Abd Malek", "ForeName": "Sri Nurestri", "Initials": "SN"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Pharmacogn Mag", "NlmUniqueID": "101300403", "ISSNLinking": "0973-1296"}, "CoiStatement": "There are no conflicts of interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Chen W, Li Z, Bai L, Lin Y. NF-kappaB in lung cancer, a carcinogenesis mediator and a prevention and therapy target. Front Biosci (Landmark Ed) 2011;16:1172\u201385.", "ArticleIdList": ["PMC3032584", "21196225"]}, {"Citation": "Brambilla E, Gazdar A. Pathogenesis of lung cancer signalling pathways: Roadmap for therapies. Eur Respir J. 2009;33:1485\u201397.", "ArticleIdList": ["PMC2762943", "19483050"]}, {"Citation": "Fadlalla K, Watson A, Yehualaeshet T, Turner T, Samuel T. Ruta graveolens extract induces DNA damage pathways and blocks Akt activation to inhibit cancer cell proliferation and survival. Anticancer Res. 2011;31:233\u201341.", "ArticleIdList": ["PMC3124362", "21273604"]}, {"Citation": "Foster I. Cancer: A cell cycle defect. Radiography. 2008;14:144\u20139."}, {"Citation": "Sethi G, Ahn KS, Aggarwal BB. Targeting nuclear factor-kappa B activation pathway by thymoquinone: Role in suppression of antiapoptotic gene products and enhancement of apoptosis. Mol Cancer Res. 2008;6:1059\u201370.", "ArticleIdList": ["18567808"]}, {"Citation": "Ngoumfo RM, Jouda JB, Mouafo FT, Komguem J, Mbazoa CD, Shiao TC, et al. In vitro cytotoxic activity of isolated acridones alkaloids from Zanthoxylum leprieurii Guill. et Perr. Bioorg Med Chem. 2010;18:3601\u20135.", "ArticleIdList": ["20413315"]}, {"Citation": "Wu TS, Shi LS, Wang JJ, Iou SC, Chang HC, Chen YP, et al. Cytotoxic and antiplatelet aggregation principles of Ruta graveolens. J Chin Chem Soc. 2003;50:171\u20138."}, {"Citation": "R\u00e9thy B, Zupk\u00f3 I, Minorics R, Hohmann J, Ocsovszki I, Falkay G. Investigation of cytotoxic activity on human cancer cell lines of arborinine and furanoacridones isolated from Ruta graveolens. Planta Med. 2007;73:41\u20138.", "ArticleIdList": ["17109253"]}, {"Citation": "Roseghini R, Moreira P, Vale V, Pinheiro AM, Costa JF, Bittencourt T, et al. Different effects of arborinine alkaloid obtained from Brazilian Erthela baihensis on spleen and thymus cells stimulated in vitro with different mitogens. Immunopharmacol Immunotoxicol. 2006;28:361\u201376.", "ArticleIdList": ["16873102"]}, {"Citation": "Orlita A, Sidwa-Gorycka M, Kumirska J, Malinski E, Siedlecka EM, Gajdus J, et al. Identification of Ruta graveolens L. metabolites accumulated in the presence of abiotic elicitors. Biotechnol Prog. 2008;24:128\u201333.", "ArticleIdList": ["18052337"]}, {"Citation": "Panno ML, Giordano F, Palma MG, Bartella V, Rago V, Maggiolini M, et al. Evidence that bergapten, independently of its photoactivation, enhances p53 gene expression and induces apoptosis in human breast cancer cells. Curr Cancer Drug Targets. 2009;9:469\u201381.", "ArticleIdList": ["19519316"]}, {"Citation": "Lee YM, Wu TH, Chen SF, Chung JG. Effect of 5-methoxypsoralen (5-MOP) on cell apoptosis and cell cycle in human hepatocellular carcinoma cell line. Toxicol In Vitro. 2003;17:279\u201387.", "ArticleIdList": ["12781206"]}, {"Citation": "An ZY, Yan YY, Peng D, Ou TM, Tan JH, Huang SL, et al. Synthesis and evaluation of graveoline and graveolinine derivatives with potent anti-angiogenesis activities. Eur J Med Chem. 2010;45:3895\u2013903.", "ArticleIdList": ["20554355"]}, {"Citation": "Oliva A, Meepagala KM, Wedge DE, Harries D, Hale AL, Aliotta G, et al. Natural fungicides from Ruta graveolens L. leaves, including a new quinolone alkaloid. J Agric Food Chem. 2003;51:890\u20136.", "ArticleIdList": ["12568545"]}, {"Citation": "Ghosh S, Bishayee K, Khuda-Bukhsh AR. Graveoline isolated from ethanolic extract of Ruta graveolens triggers apoptosis and autophagy in skin melanoma cells: A novel apoptosis-independent autophagic signaling pathway. Phytother Res. 2014;28:1153\u201362.", "ArticleIdList": ["24343999"]}, {"Citation": "Wansi JD, Hussain H, Tcho AT, Kouam SF, Specht S, Sarite SR, et al. Antiplasmodial activities of furoquinoline alkaloids from Teclea afzelii. Phytother Res. 2010;24:775\u20137.", "ArticleIdList": ["19496062"]}, {"Citation": "Njogu MK, Matasyoh JC, Kibor AC. Isolation of four furoquinoline alkaloids from Teclea nobilis and their activity against Schistosoma mansoni miracidia. J Biomed Pharm Res. 2014;3:87\u201393."}, {"Citation": "Wahyuni TS, Widyawaruyanti A, Lusida MI, Fuad A, Soetjipto Fuchino H, et al. Inhibition of hepatitis C virus replication by chalepin and pseudane IX isolated from Ruta angustifolia leaves. Fitoterapia. 2014;99:276\u201383.", "ArticleIdList": ["25454460"]}, {"Citation": "Prakash Chaturvedula VS, Schilling JK, Miller JS, Andriantsiferana R, Rasamison VE, Kingston DG. New cytotoxic alkaloids from the wood of Vepris punctata from the Madagascar rainforest. J Nat Prod. 2003;66:532\u20134.", "ArticleIdList": ["12713408"]}, {"Citation": "Richardson JS, Sethi G, Lee GS, Malek SN. Chalepin: Isolated from Ruta angustifolia L. Pers induces mitochondrial mediated apoptosis in lung carcinoma cells. BMC Complement Altern Med. 2016;16:389.", "ArticleIdList": ["PMC5059921", "27729078"]}, {"Citation": "Raman BV, La S, Saradhi MP, Rao BN, Khrisna A, Sudhakar M, et al. Antibacterial, antioxidant activity and GC-MS analysis of Eupatorium odoratum. Asian J Pharm Clin Res. 2012;5:99\u2013106."}, {"Citation": "Yang QY, Tian XY, Fang WS. Bioactive coumarins from Boenninghausenia sessilicarpa. J Asian Nat Prod Res. 2007;9:59\u201365.", "ArticleIdList": ["17365191"]}, {"Citation": "Zhang Y, Zhang H, Yao XG, Shen H, Chen J, Li C, et al. (+)-Rutamarin as a dual inducer of both GLUT4 translocation and expression efficiently ameliorates glucose homeostasis in insulin-resistant mice. PLoS One. 2012;7:e31811.", "ArticleIdList": ["PMC3288053", "22384078"]}, {"Citation": "Elliott JA., Jr Methoxsalen in the treatment of vitiligo;an appraisal of the permanency of the repigmentation. AMA Arch Derm. 1959;79:237\u201341.", "ArticleIdList": ["13616722"]}, {"Citation": "Anaya AL, Mac\u00edas-Rubalcava M, Cruz-Ortega R, Garc\u00eda-Santana C, S\u00e1nchez-Monterrubio PN, Hern\u00e1ndez-Bautista BE, et al. Allelochemicals from Stauranthus perforatus a Rutaceous tree of the Yucatan Peninsula, Mexico. Phytochemistry. 2005;66:487\u201394.", "ArticleIdList": ["15694456"]}, {"Citation": "Gomez-Flores R, Gloria-Garza MA, de la Garza-Ramos MA, Quintanilla-Licea R, Tamez-Guerra P. Antimicrobial effect of chalepensin against Streptococcus mutans. J Med Plant Res. 2016;10:631\u20134."}, {"Citation": "Emerole G, Thabrew MI, Anosa V, Okorie DA. Structure-activity relationship in the toxicity of some naturally occurring coumarins-chalepin, imperatorin and oxypeucedanine. Toxicology. 1981;20:71\u201380.", "ArticleIdList": ["7268793"]}, {"Citation": "Olorunsogo OO, Emerole GO, Malomo SO, Thabrew MI. Inhibition of mitochondrial respiration by chalepin, a naturally occurring furocoumarin. Toxicol Lett. 1983;15:323\u20137.", "ArticleIdList": ["6836600"]}, {"Citation": "Adebajo AC, Iwalewa EO, Obuotor EM, Ibikunle GF, Omisore NO, Adewunmi CO, et al. Pharmacological properties of the extract and some isolated compounds of Clausena lansium stem bark: Anti-trichomonal, antidiabetic, anti-inflammatory, hepatoprotective and antioxidant effects. J Ethnopharmacol. 2009;122:10\u20139.", "ArticleIdList": ["19095054"]}, {"Citation": "Collins K, Jacks T, Pavletich NP. The cell cycle and cancer. Proc Natl Acad Sci U S A. 1997;94:2776\u20138.", "ArticleIdList": ["PMC34145", "9096291"]}, {"Citation": "Hunter T, Pines J. Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age. Cell. 1994;79:573\u201382.", "ArticleIdList": ["7954824"]}, {"Citation": "Vermeulen K, Van Bockstaele DR, Berneman ZN. The cell cycle: A review of regulation, deregulation and therapeutic targets in cancer. Cell Prolif. 2003;36:131\u201349.", "ArticleIdList": ["PMC6496723", "12814430"]}, {"Citation": "Dickson MA, Schwartz GK. Development of cell-cycle inhibitors for cancer therapy. Curr Oncol. 2009;16:36\u201343.", "ArticleIdList": ["PMC2669234", "19370178"]}, {"Citation": "Mu\u00f1oz-Alonso MJ, Acosta JC, Richard C, Delgado MD, Sedivy J, Le\u00f3n J. p21Cip1 and p27Kip1 induce distinct cell cycle effects and differentiation programs in myeloid leukemia cells. J Biol Chem. 2005;280:18120\u20139.", "ArticleIdList": ["15746092"]}, {"Citation": "Oberoi-Khanuja TK, Murali A, Rajalingam K. IAPs on the move: Role of inhibitors of apoptosis proteins in cell migration. Cell Death Dis. 2013;4:e784.", "ArticleIdList": ["PMC3789170", "24008728"]}, {"Citation": "Schimmer AD. Inhibitor of apoptosis proteins: Translating basic knowledge into clinical practice. Cancer Res. 2004;64:7183\u201390.", "ArticleIdList": ["15492230"]}, {"Citation": "McKinlay M.A. DDW; 2011. SMAC Mimetics: a new class of targeted agents that activate apoptotic cell death and block pro-survival signalling in cancer cells; p. 37."}, {"Citation": "Owens TW, Gilmore AP, Streuli CH, Foster FM. Inhibitor of apoptosis proteins: Promising targets for cancer therapy. J Carcinog Mutagen. 2013;(Suppl 14):pii: S14-004.", "ArticleIdList": ["PMC4201371", "25328816"]}, {"Citation": "Leverson JD, Zhang H, Chen J, Tahir SK, Phillips DC, Xue J, et al. Potent and selective small-molecule MCL-1 inhibitors demonstrate on-target cancer cell killing activity as single agents and in combination with ABT-263 (navitoclax) Cell Death Dis. 2015;6:e1590.", "ArticleIdList": ["PMC4669759", "25590800"]}, {"Citation": "Besbes S, Billard C. First MCL-1-selective BH3 mimetics as potential therapeutics for targeted treatment of cancer. Cell Death Dis. 2015;6:e1810.", "ArticleIdList": ["PMC4650721", "26158516"]}, {"Citation": "Dang CT, Shapiro CL, Hudis CA. Potential role of selective COX-2 inhibitors in cancer management. Oncology (Williston Park) 2002;16(5 Suppl 4):30\u20136.", "ArticleIdList": ["12102578"]}, {"Citation": "Sobolewski C, Cerella C, Dicato M, Ghibelli L, Diederich M. The role of cyclooxygenase-2 in cell proliferation and cell death in human malignancies. Int J Cell Biol. 2010;2010:215158.", "ArticleIdList": ["PMC2841246", "20339581"]}, {"Citation": "Miller DM, Thomas SD, Islam A, Muench D, Sedoris K. c-Myc and cancer metabolism. Clin Cancer Res. 2012;18:5546\u201353.", "ArticleIdList": ["PMC3505847", "23071356"]}, {"Citation": "Dang CV. c-Myc target genes involved in cell growth, apoptosis, and metabolism. Mol Cell Biol. 1999;19:1\u201311.", "ArticleIdList": ["PMC83860", "9858526"]}, {"Citation": "Rapp UR, Korn C, Ceteci F, Karreman C, Luetkenhaus K, Serafin V, et al. MYC is a metastasis gene for non-small-cell lung cancer. PLoS One. 2009;4:e6029.", "ArticleIdList": ["PMC2696940", "19551151"]}, {"Citation": "Isra\u00ebl A. The IKK complex, a central regulator of NF-kappaB activation. Cold Spring Harb Perspect Biol. 2010;2:a000158.", "ArticleIdList": ["PMC2829958", "20300203"]}, {"Citation": "Karin M. How NF-kappaB is activated: The role of the IkappaB kinase (IKK) complex. Oncogene. 1999;18:6867\u201374.", "ArticleIdList": ["10602462"]}, {"Citation": "Sasaki CY, Barberi TJ, Ghosh P, Longo DL. Phosphorylation of RelA/p65 on serine 536 defines an IkBa-independent NF-\u03baB pathway. J Biol Chem. 2005;280:34538\u201347.", "ArticleIdList": ["16105840"]}, {"Citation": "Siveen KS, Sikka S, Surana R, Dai X, Zhang J, Kumar AP, et al. Targeting the STAT3 signaling pathway in cancer: Role of synthetic and natural inhibitors. Biochim Biophys Acta. 2014;1845:136\u201354.", "ArticleIdList": ["24388873"]}, {"Citation": "Yue P, Turkson J. Targeting STAT3 in cancer: How successful are we? Expert Opin Investig Drugs. 2009;18:45\u201356.", "ArticleIdList": ["PMC2610472", "19053881"]}, {"Citation": "Sethi G, Chatterjee S, Rajendran P, Li F, Shanmugam MK, Wong KF, et al. Inhibition of STAT3 dimerization and acetylation by garcinol suppresses the growth of human hepatocellular carcinoma in vitro and in vivo. Mol Cancer. 2014;13:66.", "ArticleIdList": ["PMC3998115", "24655440"]}, {"Citation": "Rogalska A, Gajek A, Marczak A. Epothilone B induces extrinsic pathway of apoptosis in human SKOV-3 ovarian cancer cells. Toxicol In Vitro. 2014;28:675\u201383.", "ArticleIdList": ["24583341"]}, {"Citation": "Gnesutta N, Minden A. Death receptor-induced activation of initiator caspase 8 is antagonized by serine/threonine kinase PAK4. Mol Cell Biol. 2003;23:7838\u201348.", "ArticleIdList": ["PMC207651", "14560027"]}, {"Citation": "Jain S, Dwivedi J, Jain PK, Satpathy S, Patra A. Medicinal plants for treatment of cancer: A brief review. Pharmacogn J. 2016;8:87\u2013102."}, {"Citation": "Cock I. The safe usage of herbal medicines: Counter-indications, cross-reactivity and toxicity. Pharmacogn Commun. 2015;5:2\u201338."}]}], "History": [{"Year": "2017", "Month": "1", "Day": "16"}, {"Year": "2017", "Month": "2", "Day": "22"}, {"Year": "2017", "Month": "11", "Day": "17", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "11", "Day": "17", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "11", "Day": "17", "Hour": "6", "Minute": "1"}, {"Year": "2017", "Month": "10", "Day": "1"}], "PublicationStatus": "ppublish", "ArticleIdList": ["29142404", "PMC5669087", "10.4103/pm.pm_13_17", "PM-13-489"]}}]}